「Characterization of tumour-infiltrating lymphocytes in a tumour rejection cynomolgus macaque model.」の関連論文
-
Isolation of TCR genes with tumor-killing activity from tumor-infiltrating and circulating lymphocytes in a tumor rejection cynomolgus macaque model
-
Oncolytic herpes simplex virus HF10 (canerpaturev, C-REV) promotes accumulation of CD8^+PD-1^- tumor-infiltrating T cells in PD-L1–enriched tumor microenvironment
-
Targeting of SIRPα as a potential therapy for Langerhans cell histiocytosis
-
A circulating subset of iNKT cells mediates antitumor and antiviral immunity
-
Prognostic significance of plasma interleukin-6/-8 in pancreatic cancer patients receiving chemoimmunotherapy
-
Group 1 innate lymphoid cells are involved in the progression of experimental anti-glomerular basement membrane glomerulonephritis and are regulated by peroxisome proliferator-activated receptor α
-
Differential Roles of Dendritic Cells in Expanding CD4 T Cells in Sepsis
-
CD204‑positive macrophages accumulate in breast cancer tumors with high levels of infiltrating lymphocytes and programmed death ligand‑1 expression
-
The ratio of CD8 + lymphocytes to tumor-infiltrating suppressive FOXP3 + effector regulatory T cells is associated with treatment response in invasive breast cancer
-
Reduced Number and Immune Dysfunction of CD4+ T Cells in Obesity Accelerate Colorectal Cancer Progression
-
A novel cancer immunotherapy using tumor-infiltrating B cells in the APC (min/+) mouse model
-
Development of immunotherapy using antigen-loaded multifunctional small extracellular vesicles
-
Blockade of EGFR improves responsiveness to PD-1 blockade in EGFR-mutated non–small cell lung cancer
-
In vivo induction of activin A-producing alveolar macrophages supports the progression of lung cell carcinoma
-
Optimization of the proliferation and persistency of CAR T cells derived from human induced pluripotent stem cells
-
Interleukin (IL)-17A is a potent prognostic factor associated with intratumoral neutrophil infiltration and C-X-C chemokine motif ligand 1 in triple-negative breast cancer
-
Enhancement of antitumor immune response by radiation therapy combined with dual immune checkpoint inhibitor in a metastatic model of HER2-positive murine tumor
-
Preclinical evaluation of the efficacy of an antibody to human SIRPα for cancer immunotherapy in humanized mouse models
-
Enhanced anti-tumor effects of the PD-1 blockade combined with a highly absorptive form of curcumin targeting STAT3 (本文)
-
Local, multimodal intralesional therapy renders distant brain metastases susceptible to PD-L1 blockade in a preclinical model of triple-negative breast cancer.
-
Beta-1,4-galactosyltransferase-3 deficiency suppresses the growth of immunogenic tumors in mice
-
Compromised anti-tumor–immune features of myeloid cell components in chronic myeloid leukemia patients
-
Construction of a single-cell atlas of non-hematopoietic cells in human lymph nodes and lymphoma for dissecting stromal remodeling
-
Depletion of Foxp3+ regulatory T cells augments CD4+ T cell immune responses in atherosclerosis-prone hypercholesterolemic mice
-
Identification of T cell receptors targeting a neoantigen derived from recurrently mutated FGFR3
-
Ebf3⁺ niche-derived CXCL12 is required for the localization and maintenance of hematopoietic stem cells
-
Metformin enhances the antitumor activity of oncolytic herpes simplex virus HF10 (canerpaturev) in a pancreatic cell cancer subcutaneous model
-
Effects of targeting inhibitors of plasmacytoid dendritic cell migration in immune diseases
-
Retinoic acid receptor activity is required for the maintenance of type 1 innate lymphoid cells
-
Smooth muscle protein 22α‐Cre recombination in resting cardiac fibroblasts and hematopoietic precursors
-
The therapeutic potential of multiclonal tumoricidal T cells derived from tumor infiltrating lymphocyte-derived iPS cells
-
Identification of CXCL12-abundant reticular cells in human adult bone marrow
-
Liver type 1 innate lymphoid cells lacking IL-7 receptor are a native killer cell subset fostered by parenchymal niches
-
Comprehensive analysis of TCR function using a novel system reveals the multiple unconventional tumor-reactive T cells in breast cancer-infiltrating lymphocytes
-
Tumour-immune microenvironment in duodenal-type follicular lymphoma
-
A study on the immunostimulatory effects of alarmin HMGN1 in cancer immunity
-
An Oncogenic Alteration Creates a Microenvironment that Promotes Tumor Progression by Conferring a Metabolic Advantage to Regulatory T Cells
-
Integrated analysis of tertiary lymphoid structures in relation to tumor-infiltrating lymphocytes and patient survival in pancreatic ductal adenocarcinoma
-
Aging-associated and CD4 T-cell–dependent ectopic CXCL13 activation predisposes to anti–PD-1 therapy-induced adverse events
-
Inactivation of the PD-1-dependent immunoregulation in mice exacerbates contact hypersensitivity resembling immune-related adverse events
-
Study on the regulation of CD8+ T cell immune response through nuclear receptor RORα and REV-ERB [an abstract of entire text]
-
Protocol for the isolation of mouse senescence-associated CD4⁺ T cells using flow cytometry and functional assays
-
CD45 alleviates airway inflammation and lung fibrosis by limiting expansion and activation of ILC2s
-
Re-generation of cytotoxic γδT cells with distinctive signatures from human γδT-derived iPSCs
-
Mini-TCRs: Truncated T cell receptors to generate T cells from induced pluripotent stem cells
-
cis interaction of CD153 with TCR/CD3 is crucial for the pathogenic activation of senescence-associated T cells
-
Hematopoietic cell-derived IL-15 supports NK cell development in scattered and clustered localization within the bone marrow
-
THBS1-producing tumor-infiltrating monocyte-like cells contribute to immunosuppression and metastasis in colorectal cancer
-
Interleukin-21 reduces Listeria monocytogenes secondary infection via CD8+ effector memory T cells
-
CD34+ myeloma cells with self-renewal activities are therapy-resistant and persist as MRD in cell cycle quiescence